pI: 8.0376 |
Length (AA): 668 |
MW (Da): 75171 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
37 | 667 | 2deb (A) | 32 | 652 | 36.00 | 0 | 1 | 1.43071 | -0.8 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129195)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_19470 | Choline/Carnitine o-acyltransferase family protein |
Candida albicans | CaO19.12026 | similar to mitochondrial outer carnitine acetyltransferase |
Candida albicans | CaO19.3361 | N terminus of outer carnitine acetyltransferase |
Candida albicans | CaO19.4551 | similar to mitochondrial outer carnitine acetyltransferase |
Candida albicans | CaO19.361 | C terminus of mitochondrial carnitine acetyltransferase |
Candida albicans | CaO19.10869 | N terminus of outer carnitine acetyltransferase |
Caenorhabditis elegans | CELE_R07H5.2 | Protein CPT-2, isoform B |
Drosophila melanogaster | Dmel_CG2107 | CG2107 gene product from transcript CG2107-RA |
Echinococcus granulosus | EgrG_001061200 | carnitine O palmitoyltransferase 2 |
Echinococcus multilocularis | EmuJ_001061200 | carnitine O palmitoyltransferase 2 |
Homo sapiens | ENSG00000157184 | carnitine palmitoyltransferase 2 |
Leishmania braziliensis | LbrM.22.0300 | carnitine palmitoyltransferase-like protein |
Leishmania donovani | LdBPK_220190.1 | carnitine palmitoyltransferase-like protein |
Leishmania infantum | LinJ.22.0190 | carnitine palmitoyltransferase-like protein |
Leishmania major | LmjF.22.0310 | carnitine palmitoyltransferase-like protein |
Leishmania mexicana | LmxM.22.0310 | carnitine palmitoyltransferase-like protein |
Loa Loa (eye worm) | LOAG_06314 | choline/Carnitine O-acyltransferase |
Mus musculus | ENSMUSG00000028607 | carnitine palmitoyltransferase 2 |
Saccharomyces cerevisiae | YAR035W | carnitine O-acetyltransferase YAT1 |
Schmidtea mediterranea | mk4.001868.10 | Carnitine O-palmitoyltransferase 2, mitochondrial |
Schmidtea mediterranea | mk4.001868.06 | |
Schmidtea mediterranea | mk4.001868.07 | Carnitine O-palmitoyltransferase 2, mitochondrial |
Schmidtea mediterranea | mk4.001868.14 | |
Schmidtea mediterranea | mk4.001868.12 | |
Trypanosoma brucei gambiense | Tbg972.7.2510 | carnitine O-palmitoyltransferase II, putative |
Trypanosoma brucei | Tb927.7.2250 | carnitine O-palmitoyltransferase II, putative |
Trypanosoma congolense | TcIL3000_7_1560 | carnitine O-palmitoyltransferase II, putative |
Trypanosoma cruzi | TcCLB.511807.284 | carnitine O-palmitoyltransferase II, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.2250 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.2250 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.2250 this record | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.7.2250 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_R07H5.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | carnitine palmitoyltransferase 2 | Compounds | References |
Rattus norvegicus | Carnitine palmitoyltransferase 2 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Choline acetylase | 640 aa | 29.3% | 641 aa | Compounds | References |
1 literature reference was collected for this gene.